tert-butyl 1-(2-hydroxypropyl)piperidin-4-ylcarbamate
≥95%
- Product Code: 244744
CAS:
917344-75-3
| Molecular Weight: | 258.36 g./mol | Molecular Formula: | C₁₃H₂₆N₂O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD21648271 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry, light-proof |
Product Description:
Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure allows for selective modification, making it valuable in creating compounds with improved metabolic stability and receptor binding. Commonly employed in the preparation of kinase inhibitors and neuroprotective agents. Also utilized in medicinal chemistry research for constructing peptidomimetics and enhancing drug solubility through prodrug strategies.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | €1,180.41 |
+
-
|
tert-butyl 1-(2-hydroxypropyl)piperidin-4-ylcarbamate
Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules targeting central nervous system disorders. Its structure allows for selective modification, making it valuable in creating compounds with improved metabolic stability and receptor binding. Commonly employed in the preparation of kinase inhibitors and neuroprotective agents. Also utilized in medicinal chemistry research for constructing peptidomimetics and enhancing drug solubility through prodrug strategies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :